Core Viewpoint - AlphaGen Intelligence Corp. has entered into a definitive share exchange agreement to acquire Quantum Vision Holdings Inc., which will represent a "Fundamental Change" for AlphaGen under Canadian Securities Exchange policies [1][5]. Transaction Details - AlphaGen will issue a total of 24,500,001 common shares in exchange for all outstanding shares of Quantum Vision, at a deemed value of $0.40 per AlphaGen Share [4]. - The transaction is expected to be completed by July 31, 2026, subject to the satisfaction of all conditions [2]. Shareholder Approval - Approval from AlphaGen's shareholders will be required, either through written consent from 50.01% of shareholders or at a future shareholder meeting [5]. Trading Status - Trading of AlphaGen's common shares is currently halted until all necessary documentation is filed and accepted by the CSE [3]. Proposed Leadership - Kyle Klemmer, CEO of Quantum Vision, is anticipated to become the CEO of the Resulting Issuer, while Matthew Morgan will join the board of directors [8][9]. About Quantum Vision - Quantum Vision is focused on developing post-quantum security solutions aimed at protecting critical data as cryptographic risks evolve [12]. - The company is in the development stage and has not generated any revenues since its inception, with minimal assets and liabilities [14].